Skip to content
Terry Irwin
  • Board Advisory
  • NED
  • Insights
  • About
  • Contact
  • M&A & Market Intelligence
  • Trusted counsel
  • Book a 30-min call
Menu
  • Board Advisory
  • NED
  • Insights
  • About
  • Contact
  • M&A & Market Intelligence
  • Trusted counsel
  • Book a 30-min call
  • Who on your board can tell you whether the AI roadmap is serving the business or just the momentum?

    First published on LinkedIn, 12 September 2026. Statistics updated November 2026.

    In short

    • Directors have adopted AI faster than their boards have governed it: 82 per cent have used it in their board work, and only 6 per cent sit on a board with a formal policy for it.
    • AI proposals are capital allocation decisions being overseen with the habits of a technology decision.
    • Three answers a board should have before approving: the business number and its owner, what stops, and who answers when the model is wrong.

    The paper ran to fourteen pages. Twelve of them described the technology. Two described what it would do for customers, and both of those were written in the future tense.

    Nobody in the room asked a bad question. The board asked about cost, timeline, vendor lock-in, and where the data would sit. All reasonable. All the sort of thing a competent board asks. What nobody asked was what the business would be able to do afterwards that it could not do before, stated plainly enough that someone could be held to it.

    The paper was approved.

    I have sat through enough of these to recognise the shape of it. This is not incompetence, and it is not negligence. It is a board applying the oversight habits of a technology decision to what is in fact a capital allocation decision, and the two call for different questions.

    The gap sitting inside the numbers

    Directors are not ignoring AI. In What Directors Think 2026, 38 per cent of directors named deploying AI across the business as a leading priority, and technology adoption is the top area for capital investment, cited by 42 per cent. Research by the Diligent Institute and Corporate Board Member, published in July 2026, found that 82 per cent of directors have used AI in their own board work, up from 66 per cent less than a year earlier.

    The same research found that only 6 per cent have a formal board-specific policy on how directors use it, and 54 per cent have no policy at all.

    Part of the reason is fluency. A board that isn’t confident in a domain asks about the parts of the paper it can assess, which is why AI discussions gravitate to cost, vendor, and data protection. Those are real questions, but they aren’t the governing ones. The governing question is what the business can do afterwards. Anyone can ask it, which is why it’s the board’s question rather than the technology function’s.

    Read those figures next to each other. More than four in five directors have adopted the technology personally. Fewer than one in ten sit on a board that has decided how they may use it. Adoption ran ahead of governance in the one room whose job is governance.

    The picture on results is no more comfortable. In the NACD’s 2026 Governance Outlook, 76 per cent of directors said AI will factor into their growth strategy, yet most organisations reported only slight or moderate success in realising operational or financial benefits from it so far. That is a fair description of where the technology is. It also describes a period in which a great deal of capital gets committed on the strength of direction rather than results.

    Momentum is not a business case.

    The question I have found most useful in these discussions is deliberately blunt. Is this serving the customer and the business, or is it serving the momentum?

    Momentum is not always hype. More often it is inherited. It is the strategy the company has run long enough that nobody remembers deciding on it.

    I worked with an AI business whose product was strong and whose market definition was not. The company had been founded to serve one narrow vertical, and every board discussion was a variation on how to win more of that vertical. The technology roadmap followed the market definition without testing whether it still held.

    The question that moved the discussion wasn’t about the technology. What does this capability do that has nothing to do with the market we chose at the start?

    The answer was cross-vertical automation and optimisation. Financial services was the first market to open, but it wasn’t the market the company had been built around. Repositioning around that capability moved the business from competing for share of one vertical to selling a capability into several. The addressable market didn’t enlarge; it was redefined. The product barely changed. The definition of what the company was for changed completely.

    That is what the momentum question is for. It does not ask whether the technology works. It asks whether the thing the technology is being pointed at is still the right thing.

    The seam where these decisions fail

    I have been on the wrong side of the same gap myself, in a different context.

    Leading a post-acquisition integration for a multinational consumer and industrial goods group, I had board approval, a plan and a clear mandate. What I didn’t have was dedicated resourcing, and I didn’t push hard enough when the board approved the outcome without deciding what we’d give up to get there. The integration stretched to two years. It should have taken about half that time, and the extra year included two field sales forces where one was needed, a duplicated management layer above them, and a second set of systems underneath. Reconstructed at today’s costs, that is somewhere around five and a half million pounds of avoidable spend. It is a reconstruction rather than a figure anyone produced at the time, and that is the part worth noticing. Since no one was asked to own the number, no one produced one.

    I have run every integration since on the lesson: a board that approves an outcome without resourcing the route to it has not made a decision; it has expressed a preference.

    AI proposals fail in that same seam far more often than they fail technically. The model works. The pilot works. Then the capacity it was supposed to release is never reallocated, the process it was supposed to replace runs alongside it for another eighteen months, and the business case quietly becomes a cost.

    Three answers a board should have before it approves

    Not three questions to ask the CTO. Three answers the board itself should be able to give, in its own words, before the paper is approved.

    1. What changes in the business if this works, stated as a number, and which executive owns that number? General efficiency is not an answer. A percentage against a named line, owned by a named person, is.
    2. What does the organisation stop doing? Capacity released and never reallocated is a saving on paper and a cost in practice. If nothing stops, nothing has been saved.
    3. What is the exposure when the model is wrong, and who answers for it? Not who maintains the system. Who answers for the decision it made.

    If those three answers don’t exist, the decision isn’t ready, no matter what the technology is worth.

    None of the three requires the board to understand the model. They require the board to insist that business consequences are considered with the same rigour as technology, and to notice when they aren’t.

    A board that cannot say what an AI investment is supposed to change is not overseeing that investment; it is watching it.

    And if most of your directors are already using AI in their board work while the board has never written down how they may use it, that is the first paper to commission, not the last.

    Terry Irwin is a Non-Executive Director and Board Adviser in the UK and Europe, and helps boards test AI claims, spend and risk. More on his work: AI at board level.

    Terry Irwin

    8 November 2026
  • AI decisions boards are getting wrong

    Most boards are approaching AI the wrong way. Not because they’re ignoring it. Quite the opposite. Boards are holding AI strategy sessions, commissioning vendor reports, and adding “AI oversight” to committee charters.

    The problem: they’re treating AI as a governance topic when it should be a commercial opportunity.

    Here’s what boards are getting wrong, and how to reframe the discussion.

    MISTAKE 1: Treating AI as risk management, not value creation

    Most board-level AI discussions start with risk:

    • What are the regulatory implications?
    • How do we mitigate algorithmic bias?
    • What’s our data governance framework?

    These are important questions. But if that’s where the discussion stays, the board is missing the point.

    AI isn’t primarily a risk management topic. It’s a commercial leverage opportunity, and boards should be asking:

    • Where can AI compress cycle time or reduce cost-to-serve by 30-50%?
    • Which customer pain points could AI solve better than current solutions?
    • What proprietary data do we have that could become a competitive moat if we applied AI effectively?

    The best boards I’ve worked with flip the sequence: start with commercial opportunity, then layer in governance and risk management to protect the value being created. Risk-first AI discussions lead to slow, cautious implementation.

    Opportunity-first discussions lead to disciplined experimentation with clear ROI targets.

    MISTAKE 2: Delegating AI to the CTO (or worse, a consultant)

    I see this pattern repeatedly: board asks CTO or Chief Data Officer to “lead our AI strategy”, then receives a 40-slide deck full of technology architecture and vendor comparisons.

    The problem: AI strategy isn’t a technology question. It’s a business model question.

    The critical AI decisions boards need to make aren’t:

    • Which LLM provider should we use?
    • Should we build or buy AI capability?

    The critical decisions are:

    • Which parts of our business model could AI fundamentally reshape?
    • Are we deploying AI to defend current margins, or to attack new markets?
    • What happens to our workforce, our pricing, our customer relationships if AI delivers what vendors promise?

    These aren’t CTO questions. These are CEO and board-level strategy questions that require commercial judgment, not technical expertise.

    By delegating AI to the technology team, boards abdicate responsibility for the commercial decisions that matter most.

    MISTAKE 3: Accepting vendor prmomises without proof

    AI vendors are very good at selling the future:
    “Our AI will reduce customer support costs by 40%.”

    “Our platform will increase sales productivity by 3x.”

    “Deployment takes 6-8 weeks with minimal disruption.”

    Boards hear these promises, nod approvingly, and approve

    budgets. Six months later, the AI project is behind schedule, over

    budget, and delivering 20% of promised value.

    Why? Because boards aren’t asking the right questions:

    • What’s the proof this works in OUR context (not a generic case study)?
    • What assumptions underpin the ROI model?
    • What needs to be true operationally for this to deliver promised value?
    • What’s the kill criterion if it’s not working after 90 days

    The best boards I work with treat AI deployment like commercial diligence:

    • Pilot first (small, defined scope)
    • Measure rigorously (actual results vs vendor promises)
    • Scale only after proof (don’t enterprise-deploy on faith)

    This isn’t anti-innovation. It’s commercial discipline.

    MISTAKE 4: No clear ownership of AI value delivery

    Most boards know someone should “own AI strategy.” But when I ask “Who’s accountable for AI delivering commercial value?”, the answer is often vague.

    “We have an AI steering committee.”

    “The CTO is leading it, with input from the CEO.”

    “It’s a cross-functional initiative.”

    Translation: no one owns it.

    AI projects that succeed have clear ownership:

    • One executive (typically CEO, COO, or Chief Commercial Officer) owns the P&L impact of AI deployment
    • That executive reports AI progress to the board monthly (not quarterly)
    • Success is measured in commercial outcomes (revenue, margin, customer satisfaction), not AI deployment metrics (models trained, data pipelines built)

    If the board can’t name the executive who’ll be fired if AI doesn’t deliver value, the governance structure is broken.

    What good looks like: The three questions boards should ask

    Instead of “Do we have an AI strategy?”, which inevitably produces a 50-slide deck and no action, boards should ask three specific questions:

    1. WHERE HAVE WE RUN A 90-DAY AI PILOT WITH MEASURABLE ROI?

    Not “Where are we planning to use AI?”, where have we actually deployed it, measured results, and proven value?

    If the answer is “nowhere yet”, the board should ask why. AI is not a 2027 strategy topic. It’s a 2026 execution topic.

    2. WHAT’S THE COMMERCIAL CASE FOR SCALING AI BEYOND THE PILOT

    If the pilot worked, what’s the business case for scaling across the organization?

    This forces the team to connect AI deployment to commercial outcomes:

    • If we scale this AI tool across 500 customer support agents, what’s the margin impact?
    • If we deploy this in sales, what’s the revenue uplift vs cost of deployment?

    If the team can’t build a clear commercial case, don’t scale.

    3. WHO OWNS AI VALUE DELIVERY, AND WHAT’S THEIR 90-DAY SCORECARD?

    Who’s accountable? What are they measured on? What happens if AI doesn’t deliver?

    These questions force clarity and accountability, which is what boards are supposed to provide.

    The bottom line

    AI is not a governance checkbox. It’s a commercial opportunity that requires the same discipline boards apply to M&A, international expansion, or major product launches:

    • Clear business case
    • Pilot before scaling
    • Measure actual results vs promises
    • Assign ownership and accountability

    Boards that treat AI this way will capture value. Boards that treat it as a risk management topic will watch competitors move faster.

    Terry Irwin

    15 April 2026

Copyright © 2026 TCii Limited trading as Terry Irwin

Email me at: terry@terryirwin.com Call me on: +44 (0)20 7099 2621

  • Terms and conditions
  • Privacy policy
  • Website terms and conditions of use
  • Data protection policy

Registered address: Terry Irwin, 12 Brentcot Close, London W13 8EH • Registered in England No: 5257609 | VAT No: 848 4797 62

Book a 30-minute intro call
  • LinkedIn
  • YouTube